Publicaciones en colaboración con investigadores/as de Mutua de Terrassa (32)

2026

  1. Biological therapies for inflammatory pouch disorders: insights and outcomes from the RESERVO study of GETECCU

    Therapeutic Advances in Gastroenterology, Vol. 19

  2. Cost-effectiveness of personalized medical treatment in acromegaly: A post hoc analysis of the ACROFAST study

    Journal of the Endocrine Society, Vol. 10, Núm. 4

  3. Effectiveness and Persistence of Long-Acting Injectable Cabotegravir and Rilpivirine in Migrant Individuals Living With HIV in Spain: Substudy of the RELATIVITY Cohort

    Journal of the International AIDS Society, Vol. 29, Núm. 4

  4. Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera

    Blood Cancer Journal

  5. Influence of the level of education on cognitive function in Parkinson’s disease

    Journal of Neural Transmission, Vol. 133, Núm. 4, pp. 663-681

  6. Long-acting cabotegravir and rilpivirine in people with HIV and obesity: Real-world outcomes from the RELATIVITY cohort

    HIV Medicine, Vol. 27, Núm. 5, pp. 690-709

  7. Lumen-Apposing Stents With or Without Pigtail in Endosonography-Guided Biliary Drainage for Malignant Distal Biliary Obstruction

    Clinical Gastroenterology and Hepatology, Vol. 24, Núm. 3, pp. 678-687.e21

  8. Response to therapy and prognosis according to molecular characterization in CALR-mutated essential thrombocythemia

    HemaSphere, Vol. 10, Núm. 3

2025

  1. A prospective assessment of the efficacy and durability of long-acting cabotegravir and rilpivirine in individuals with HIV in Spain (RELATIVITY study)

    Journal of Antimicrobial Chemotherapy, Vol. 80, Núm. 12, pp. 3438-3451

  2. Characterization of thrombosis risk in ambulatory patients with cancer: Results of the observational, prospective, multicenter CARTAGO study

    Oncologist, Vol. 30, Núm. 8

  3. Correction to: Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline (Journal of Neurology, (2025), 272, 3, (246), 10.1007/s00415-024-12808-0)

    Journal of Neurology

  4. Health-related quality of life determinants in Spanish children with eosinophilic esophagitis

    Journal of Pediatric Gastroenterology and Nutrition, Vol. 80, Núm. 2, pp. 308-317

  5. Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

    Journal of Neurology, Vol. 272, Núm. 3

  6. Increased mortality and morbidity risk in people with early HIV care interruption in Spain

    AIDS, Vol. 39, Núm. 9, pp. 1224-1234

  7. Long-term effectiveness and tolerability of dolutegravir/lamivudine in treatment-naive people with HIV: an analysis of a multicentre cohort at 96?weeks

    The Journal of antimicrobial chemotherapy, Vol. 80, Núm. 3, pp. 682-691

  8. Mechanical power is not associated with mortality in COVID-19 mechanically ventilated patients

    Annals of Intensive Care, Vol. 15, Núm. 1

  9. Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly

    Pituitary, Vol. 28, Núm. 6

  10. Types, behaviour and therapeutic requirements of inflammatory pouch disorders: Results from the RESERVO study of GETECCU

    Digestive and Liver Disease, Vol. 57, Núm. 2, pp. 566-573

2024

  1. A Prospective, Multicenter, Real-World Registry of Coronary Lithotripsy in Calcified Coronary Arteries: The REPLICA-EPIC18 Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 6, pp. 756-767

  2. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

    AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314